Please login to the form below
Spain
This page shows the latest Spain news and features for those working in and with pharma, biotech and healthcare.
Abivax doses first patient in phase 2b/3 COVID-19 clinical trial
It also plans to obtain further authorisations in Spain and additional Latin American countries with high infection rates.
Latest news
-
Policy and public health COVID-19 by the numbers
These eight countries account for 40% of confirmed cases worldwide: Spain, Italy, UK, Germany, France, Belgium, Netherlands, Switzerland. ... This is the highest rate in the world and surpasses that of Spain, Italy, France and the UK.
-
Sanofi doses first patient in global Kevzara COVID-19 trial
Sanofi, which is leading the Kevzara (sarilumab) trials outside the US, announced that the first patient had been dosed today, as the phase 2/3 trial is initiated in Italy, Spain,
-
Did Trump offer CureVac $1bn for COVID-19 vaccine rights?
gathers pace, as other countries like Italy, Spain and Germany implement lockdowns and border controls.
-
UK is a leader in early clinical research but falls in later study stages, says ABPI
In 2017, the UK ranked fifth globally for phase 3 trials, behind Germany, Spain, the US and Canada.
-
The NHS is facing shortages of lifesaving treatments, says internal document
The Government noted that 19 HRT drugs are covered by the restrictions, which are also in place in other EU countries including France and Spain.
More from news
Approximately 10 fully matching, plus 347 partially matching documents found.
Latest Intelligence
-
The flexible salesforce
In Spain, other channels went from 12% of total activity in January to 94% in May, Italy 9% to 96% and Brazil 15% to 89% (Figure 2). ... In Spain the baseline was 4% of total promotional activity in January, rising to 49% in May and remaining at 38% in
-
The power of remote personal interactions: COVID-19 pandemic and the increasing role of remote engagement
Nevertheless, in some countries, it has become the third most used channel after email and phone engagement (eg, Spain, Brazil and the USA).
-
Addressing the payer-regulator evidence gap in early-stage cancer
In December 2018, IQVIA and AstraZeneca conducted a blinded survey of 65 payers in eight countries (Australia, Canada, France, Germany, Italy, Spain, UK, USA) which found a lower awareness of
-
Things are going to be different
China has a near 600% increase, Korea 165%, Italy 286% and Spain 145%.
-
GSK forges ahead with its dynamic COPD and asthma portfolio
For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.
More from intelligence
Approximately 2 fully matching, plus 50 partially matching documents found.
Latest appointments
-
STEM Healthcare bolsters its EU5 team
Enrique Cruz-Jentoft (pictured right) has joined the agency as its general manager for Spain following pharmaceutical industry experience gained from servingand MSD.
-
Minoryx Therapeutics adds to board of directors
Dr Claude Nicaise joins as an independent board member. Dr Claude Nicaise has joined Barcelona, Spain-based Minoryx Therapeutics as an independent board member.
-
Caldan Therapeutics bolsters senior team
Most recently, Dr Connolly served as scientific leader with Almirall, based in Barcelona, Spain.
-
ClinTec appoints regional manager for Spain and Portugal
Carlos Palacios joins the contract research organisation. Contract research organisation ClinTec International has appointed Carlos Palacios to the newly-created position of regional manager for Spain and Portugal. ... Palacios joins ClinTec from Merck,
-
Sonia Ruiz Moran appointed president of EMVO
She comes to the EMVO with a wealth of pharma experience, having led European Public Affairs at the General Pharmaceutical Council of Spain, since 2008. ... Prior to joining the General Pharmaceutical Council of Spain, Ruiz Moran worked at Prisa, a
More from appointments
Approximately 1 fully matching, plus 18 partially matching documents found.
Latest from PMHub
-
Homeworking: The positives and tips from the experience of the Valid Insight Team
At Valid Insight, we have had a homeworking model since our inception; a model designed to enable us to attract and recruit experienced professionals from many geographies, without the need to uproot family, travel regularly or experience long
-
Pricing and Market Access Simulator
Germany, Italy, Netherlands, Poland, Portugal, Scotland, Spain, Sweden, and US.
-
Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports
The AS 5EU report comprises of interviews with 385 patients in France, Germany, Italy, Spain and UK, while the AS US report is based on a study of 136 patients.
-
3DforScience - Visuals for Bio & Health
Address:. Nuñez de Balboa 120. Cink Building madrid. Spain. 28006. Spain.
-
Report: Living with RA (EU, Japan and Canada) 2019 reports
Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK) and 55 patients in
More from PMHub
Approximately 0 fully matching, plus 45 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gilead agrees $21bn buyout of Immunomedics
- New medical communications agency BOLDSCIENCE launches
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
